AAPLOG

AAPLOG Files Citizen Petition on Mifepristone (Mifeprex) with FDA

AAPLOG Files Citizen Petition on Mifepristone (Mifeprex) with FDA Holland, Michigan—The American Association of Pro-Life Obstetricians and Gynecologists, together with the Christian Medical Association and Concerned Women for America, filed a response on August 20 with the Food & Drug Administration requesting immediate revocation of the approval of Mifeprex (RU-486), the abortion pill. The petition […]

AAPLOG Files Citizen Petition on Mifepristone (Mifeprex) with FDA Read More »

Letter to ACOG Regarding Mifepristone (Mifeprex) Advocacy

May 23, 2002 Ralph Hale, M.D. Executive Vice President The American College of Obstetricians and Gynecologists 409 12th Street, S.W. Washington, D.C. 20090-6920 Dear Dr. Hale: We write to object to your prior efforts, purportedly on behalf of the American College of Obstetricians and Gynecologists, to compromise the FDA’s proposed restrictions on the use of

Letter to ACOG Regarding Mifepristone (Mifeprex) Advocacy Read More »

Human Cloning

The membership of the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG) considers it unethical to attempt the cloning of human beings, or to create human embryos via cloning, for any purpose. We believe that a new human life normally begins at conception with the union of an egg from a women and a sperm

Human Cloning Read More »

Breast Cancer

The association of induced abortion and the subsequent development of breast cancer. Letter to incoming ACOG President Hammond Letter in 2001, urging academically balanced examination of the evidence for an association between induced abortion and subsequent development of breast cancer.…

Breast Cancer Read More »

AAPLOG Statement on FDA Approval of Mifeprex (RU 486)

On September 28, 2000 the United States Food and Drug Administration (FDA) announced the approval of mifepristone, in combination with misoprostol, for early pregnancy termination.1 This decision received the unqualified approval of the American College of Obstetricians and Gynecologists (ACOG). Mifepristone is also known as RU 486 and is marketed in the United States under

AAPLOG Statement on FDA Approval of Mifeprex (RU 486) Read More »

AAPLOG letter to ACOG, detailing our objections to the ACOG policy

AAPLOG Response to ACOG Executive Board Statement of Policy Re: “Partial Birth Abortion,” dated 12 Jan 97. The American Association of ProLife Obstetricians and Gynecologists Feb 1997 Fredric D. Frigoletto, Jr., M.D., President Executive Board American College of Obstetricians and Gynecologists 409 12th Street, SW P.O. Box 96920 Washington, D.C. 20090-6920 Dear Dr. Frigoletto, We

AAPLOG letter to ACOG, detailing our objections to the ACOG policy Read More »

AAPLOG Statement on Partial Birth Abortion

THE AMERICAN ASSOCIATION OF PROLIFE OBSTETRICIANS AND GYNECOLOGISTS AAPLOG Statement on Partial Birth Abortion February, l997 The American Association of ProLife Obstetricians and Gynecologists is strongly opposed to the procedure known to the general public as “Partial Birth Abortion”, and known in medical terminology as “Intact Dilatation and Extraction,” or “intact D&X.” This medical terminology was

AAPLOG Statement on Partial Birth Abortion Read More »